Cargando…
Alemtuzumab-induced alopecia universalis and transient accommodation spasm in a patient with multiple sclerosis
Herein, we report a case of alopecia universalis and transient accommodation spasm presented after alemtuzumab administration in a patient previously treated with fingolimod. To the best of our knowledge, this is the first report of accommodation spasm as an acute adverse effect of alemtuzumab. Trea...
Autores principales: | Tzanetakos, Dimitrios, Breza, Marianthi, Tzartos, John S., Bontzos, Georgios, Vakrakou, Aigli G., Dermentzoglou, Alexandros, Gkizis, Ilias, Smoustopoulos, Georgios, Evangelopoulos, Maria-Eleptheria, Stefanis, Leonidas, Kilidireas, Costantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549181/ https://www.ncbi.nlm.nih.gov/pubmed/36225970 http://dx.doi.org/10.1177/17562864221127476 |
Ejemplares similares
-
Thyroid Autoimmunity Following Alemtuzumab Treatment in Multiple Sclerosis Patients
por: Kazakou, Paraskevi, et al.
Publicado: (2021) -
Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study
por: Kazakou, Paraskevi, et al.
Publicado: (2023) -
Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature
por: Vakrakou, Aigli G., et al.
Publicado: (2020) -
Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases
por: Vakrakou, Aigli G., et al.
Publicado: (2021) -
A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes
por: Vakrakou, A. G., et al.
Publicado: (2018)